Following this, Jeffers et al. investigated 70 as a potential treatment for bleomycin-mediated pulmonary fibrosis (PF) as myofibroblast differentiation and pulmonary fibrosis are induced by the GSK-3β signalling pathway, ex vivo and in vivo, respectively [62]. Here, GSK3B is linked to pulmonary fibrosis.